Metabolic Syndrome and Risk of Cancer

Abstract

OBJECTIVEAvailable evidence supports the emerging hypothesis that metabolic syndrome may be associated with the risk of some common cancers. We did a systematic review and meta-analysis to assess the association between metabolic syndrome and risk of cancer at different sites.RESEARCH DESIGN AND METHODSWe conducted an electronic search for articles published through October 2011 without restrictions and by reviewing reference lists from retrieved articles. Every included study was to report risk estimates with 95% CIs for the association between metabolic syndrome and cancer.RESULTSWe analyzed 116 datasets from 43 articles, including 38,940 cases of cancer. In cohort studies in men, the presence of metabolic syndrome was associated with liver (relative risk 1.43, P < 0.0001), colorectal (1.25, P < 0.001), and bladder cancer (1.10, P = 0.013). In cohort studies in women, the presence of metabolic syndrome was associated with endometrial (1.61, P = 0.001), pancreatic (1.58, P < 0.0001), breast postmenopausal (1.56, P = 0.017), rectal (1.52, P = 0.005), and colorectal (1.34, P = 0.006) cancers. Associations with metabolic syndrome were stronger in women than in men for pancreatic (P = 0.01) and rectal (P = 0.01) cancers. Associations were different between ethnic groups: we recorded stronger associations in Asia populations for liver cancer (P = 0.002), in European populations for colorectal cancer in women (P = 0.004), and in U.S. populations (whites) for prostate cancer (P = 0.001).CONCLUSIONSMetabolic syndrome is associated with increased risk of common cancers; for some cancers, the risk differs betweens sexes, populations, and definitions of metabolic syndrome.

Obesity accelerates epigenetic aging of human liver

“…Obesity is an established risk factor for many types of cancers, particularly for HCC, because of its carcinogenic potential and the association with NAFLD (33). In cohort studies in men, metabolic syndrome was most strongly associated with liver cancer followed by colorectal cancer (34). Future studies will be needed to test whether tissues with increased DNAm age have a lower threshold to carcinogenesis.…”

Molecular targets for the therapy of cancer associated with metabolic syndrome (transcription and growth factors)

“…[1][2][3] MS is one of the leading risk factors for the development of cardiovascular diseases, diabetes mellitus type II and pathology of the reproductive system, thus leading to severe concomitant diseases and decreased life expectancy in patients.…”

Obesity and Obese-related Chronic Low-grade Inflammation in Promotion of Colorectal Cancer Development

“…The role of imbalanced metabolism (MetS) distinct immune cells, cytokines, and other immune mediators are suggested in the development of the inflammatory process (Esposito et al, 2012;Kabat et al, 2012).…”